Coherus Oncology, Inc. (CHRS)
Coherus Oncology Market Cap : 248.34M for May 22, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| BioMarin Pharmaceutical, Inc. | 10.45B |
| Inovio Pharmaceuticals, Inc. | 111.07M |
| Myriad Genetics, Inc. | 360.79M |
| Vaxart, Inc. | 156.02M |
| BioRestorative Therapies, Inc. | 5.300M |
Market Cap Related Metrics
| PS Ratio | 4.199 |
| Price to Book Value | 3.159 |
| Price | 1.61 |
| Earnings Yield | -77.40% |